New Breath Test Determines Epilepsy Drug Regimen

When it comes to treating epilepsy, each patient needs a custom tailored regimen because the difference between a therapeutic dose and a toxic one is very small. A recent Medgadget article discussed a new breath test that can quickly determine the optimal drug treatment approach for each patient. The test was developed by researchers at Switzerland’s University of Basel, and it helps outline metabolic hallmarks to help clinicians determine the efficacy of a medication.